Sanofi gets CDSCO panel okay to market Quadrivalent Inactivated Influenza vaccine

Quadrivalent Influenza Vaccine (split virion, inactivated) is a vaccine. This vaccine administered to child from 6 months of age helps to protect against influenza (flu).

Flu is a disease that can spread rapidly and is caused by different types of strains that can change every year. Due to this potential change in circulating strains on a yearly basis, as well as the duration of protection intended by the vaccine, vaccination is recommended every year.

Quadrivalent Influenza Vaccine (split virion, inactivated) is intended to protect one against the four strains of virus contained in the vaccine about 2 to 3 weeks after the injection. It is indicated for the prevention of influenza disease caused by the two influenza A virus subtype and two influenza B virus types contained in the vaccine.

When a person is given Quadrivalent Influenza Vaccine (split virion, inactivated), the immune system (the body's natural defence system) will produce its own protection (antibodies) against the disease. When given during pregnancy the vaccine helps to protect the pregnant women but also helps to protect her baby from birth to less than 6 months of age through the transmission of protection from mother to baby during pregnancy.

Earlier, the Medical Dialogues Team had reported that Sanofi Pasteur, the vaccine division of Sanofi, had announced the launch of its 4-strain influenza vaccine FluQuadri in India which was India's first quadrivalent vaccine to provide broader protection against influenza to population above three years of age.

FluQuadri (Quadrivalent Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde.